TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11554438

Group type: EXPERIMENTAL
Intervention: Theophylline (250 mg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Theophylline (375 mg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Theophylline (500 mg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Theophylline (all doses)
Number of subjects: 6
Study: 9755997

Group type: EXPERIMENTAL
Intervention: Omeprazole (PPI) administered through a jejunal tube after PPPD
Number of subjects: 42

Group type: COMPARATOR
Intervention: Saline solution administered through a jejunal tube (Control group)
Number of subjects: 42
Study: 8148274

Group type: EXPERIMENTAL
Intervention: 4% w/v erythromycin with 1.2% w/v zinc acetate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 4% w/v erythromycin alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both erythromycin with and without zinc
Number of subjects: 0
Study: 3280316

Group type: EXPERIMENTAL
Intervention: Intravenous amiodarone 5 mg kg‐1 with Tween 80 (A)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Intravenous amiodarone 5 mg kg‐1 without Tween 80 (N)
Number of subjects: 20
Study: 29797913

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with western medication (dehydration and nutritional nerve treatment), treatment given once daily for 6 times per course, with 4 courses total.
Number of subjects: 64

Group type: COMPARATOR
Intervention: Western medication (dehydration and nutritional nerve treatment) alone.
Number of subjects: 64
Study: 28169487

Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 26062002

Group type: EXPERIMENTAL
Intervention: HPV-16/18(2D)
Number of subjects: 1075
Study: 22917636

Group type: EXPERIMENTAL
Intervention: Arm 2 (bisacodyl the day before and 2-L polyethylene glycol with citrates and simethicone on the day of colonoscopy)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Control group (split-dose of 4-L polyethylene glycol)
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Arm 1 (bisacodyl and 2-L polyethylene glycol with citrates and simethicone the day before)
Number of subjects: 153
Study: 20697940

Group type: EXPERIMENTAL
Intervention: Tianhuang Granule (THG)
Number of subjects: 60
Study: 18403671

Group type: EXPERIMENTAL
Intervention: 0.4 mg of salbutamol aerosol with a spacer device for bronchodilation
Number of subjects: 628
Study: 15684169

Group type: EXPERIMENTAL
Intervention: Metoclopramide 10 mg, 3 times a day for 10 days
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Metoclopramide
Number of subjects: 69
Study: 12604505

Group type: EXPERIMENTAL
Intervention: Sodium lactate infusion (60 micromol x kg(‐1) x min(‐1))
Number of subjects: 7

Group type: COMPARATOR
Intervention: Isomolar sodium bicarbonate infusion
Number of subjects: 7
Study: 10535525

Group type: EXPERIMENTAL
Intervention: Desferrioxamine (DFO) infusion
Number of subjects: 40

Group type: COMPARATOR
Intervention: No DFO infusion
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Patients with beta-thalassemia major
Number of subjects: 40
Study: 8724510

Group type: EXPERIMENTAL
Intervention: Spermicide as a Backup
Number of subjects: 199

Group type: COMPARATOR
Intervention: Condoms Only
Number of subjects: 199

Group type: COMPARATOR
Intervention: Condom and Spermicide
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 199
Study: 1768540

Group type: EXPERIMENTAL
Intervention: Paravertebral bupivacaine (PVB) infusion
Number of subjects: 20

Group type: COMPARATOR
Intervention: Paravertebral saline (PVS) infusion
Number of subjects: 20
Study: 462160

Group type: EXPERIMENTAL
Intervention: Corynebacterium parvum intrapleurally as adjuvant therapy
Number of subjects: 475

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 475
Study: 30360637

Group type: EXPERIMENTAL
Intervention: Wood smoke exposure (500 μg/cm3)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Filtered air (control)
Number of subjects: 39
Study: 28380672

Group type: EXPERIMENTAL
Intervention: Active DBS
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sham
Number of subjects: 10
Study: 23932139

Group type: EXPERIMENTAL
Intervention: Long-chain inulin (20g/L) added to low-fat yogurt
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lactobacillus paracasei ssp. paracasei added to low-fat yogurt
Number of subjects: 0

Group type: COMPARATOR
Intervention: Full-fat yogurt
Number of subjects: 0
Study: 21282579

Group type: EXPERIMENTAL
Intervention: Progressive-addition lenses (PALs) with a +2.00-D addition
Number of subjects: 118

Group type: COMPARATOR
Intervention: Single-vision lenses (SVLs)
Number of subjects: 118
Study: 19967885

Group type: EXPERIMENTAL
Intervention: Antibiotic prophylaxis
Number of subjects: 1400

Group type: COMPARATOR
Intervention: No antibiotic prophylaxis
Number of subjects: 1400
Study: 17403972

Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy (CBT) guided self-care
Number of subjects: 85

Group type: COMPARATOR
Intervention: Family therapy
Number of subjects: 85
Study: 15379418

Group type: EXPERIMENTAL
Intervention: Diabetic patients with acute ketoacidosis
Number of subjects: 38

Group type: COMPARATOR
Intervention: Healthy children (control group)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Diabetic patients with pH > or =7.0
Number of subjects: 38
Study: 11174349

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 9569984

Group type: EXPERIMENTAL
Intervention: Bare incisors
Number of subjects: 15

Group type: COMPARATOR
Intervention: Capped incisors
Number of subjects: 15

Group type: COMPARATOR
Intervention: Bare molars
Number of subjects: 15
Study: 8312766

Group type: EXPERIMENTAL
Intervention: Antiplatelet therapy
Number of subjects: 8000
Study: 2973588

Group type: EXPERIMENTAL
Intervention: Ceftazidime + amikacin (CA)
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Ceftazidime + pefloxacin (CP)
Number of subjects: 212

Group type: COMPARATOR
Intervention: Ceftazidime + pefloxacin (CP) and Ceftazidime + amikacin (CA)
Number of subjects: 212
Study: 30935010

Group type: EXPERIMENTAL
Intervention: Protein/glucose shake
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Combination of white bread and sour milk cheese (food)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Nothing (control)
Number of subjects: 35
Study: 28520812

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) activated with calcium chloride and bovine thrombin, placed into the osteotomy at the time of surgery.
Number of subjects: 64

Group type: COMPARATOR
Intervention: Saline lavage of the osteotomy (Control group).
Number of subjects: 64
Study: 25530603

Group type: EXPERIMENTAL
Intervention: School support (school fees, uniforms, school supplies, school-based helper)
Number of subjects: 328

Group type: COMPARATOR
Intervention: Control group (delayed partial treatment of school fees only)
Number of subjects: 328
Study: 23400614

Group type: EXPERIMENTAL
Intervention: School-Based Asthma Therapy (SBAT) program - administration of 1 dose of preventive asthma medication at school by the school nurse each school day.
Number of subjects: 525

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 525
Study: 20830497

Group type: COMPARATOR
Intervention: inlay without fiber post (G1)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: inlay with long fiber post (G2)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: inlay with short fiber post (G3)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: onlay without fiber post (G4)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: onlay with long fiber post (G5)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: onlay with short fiber post (G6)
Number of subjects: 70

Group type: COMPARATOR
Intervention: intact teeth (control)
Number of subjects: 70
Study: 19108788

Group type: EXPERIMENTAL
Intervention: Azithromycin 1% ophthalmic solution
Number of subjects: 48

Group type: COMPARATOR
Intervention: Moxifloxacin 0.5% ophthalmic solution
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Both treatments (Azithromycin and Moxifloxacin)
Number of subjects: 48
Study: 17414766

Group type: EXPERIMENTAL
Intervention: 40 mL of contrast material (350 mg of Iodine per milliliter)
Number of subjects: 60

Group type: COMPARATOR
Intervention: 50 mL of contrast material (350 mg of Iodine per milliliter)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Contrast volume > 0.9 mL/kg body weight
Number of subjects: 60
Study: 15355127

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil 500 mg twice daily
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group (without mycophenolate mofetil)
Number of subjects: 19
Study: 11436969

Group type: EXPERIMENTAL
Intervention: Azelastine nasal spray and eye drops
Number of subjects: 99

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study: 9752515

Group type: EXPERIMENTAL
Intervention: Initial chemotherapy followed by locoregional treatment (Group B, n = 134)
Number of subjects: 272

Group type: COMPARATOR
Intervention: Mastectomy and axillary node dissection (Group A, n = 138)
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: Overall survival rate at 10 years
Number of subjects: 272
Study: 7826821

Group type: EXPERIMENTAL
Intervention: Quinine sulphate 600 mg
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control (non-diabetic)
Number of subjects: 22
Study: 3288172

Group type: EXPERIMENTAL
Intervention: Functional Electric Stimulation (FES)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Combined therapy with Biofeedback (BFB) and FES
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Biofeedback (BFB)
Number of subjects: 36
Study: 29992264

Group type: EXPERIMENTAL
Intervention: Standardized classification and framework for reporting medication non-adherence
Number of subjects: 0
Study: 28592458

Group type: EXPERIMENTAL
Intervention: WARM (37.6°C)
Number of subjects: 8

Group type: COMPARATOR
Intervention: COOL (29.4°C)
Number of subjects: 8
Study: 24438385

Group type: EXPERIMENTAL
Intervention: Restorative home-care service
Number of subjects: 750
Study: 23086792

Group type: EXPERIMENTAL
Intervention: Transendocardial injection of bone marrow-derived mononuclear cells (BMC)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Matched control group from LIPSIAbciximab-STEMI trial
Number of subjects: 12
Study: 19175512

Group type: EXPERIMENTAL
Intervention: Insuflon (subcutaneous injection port)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Alarmable blood glucose meter
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 66
Study: 17151799

Group type: EXPERIMENTAL
Intervention: Treadmill walking (TW) program
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (regular physical education curriculum)
Number of subjects: 10
Study: 15860712

Group type: EXPERIMENTAL
Intervention: 9 g PUFA daily
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 11915059

Group type: EXPERIMENTAL
Intervention: 0.25% bupivacaine (group B)
Number of subjects: 30

Group type: COMPARATOR
Intervention: saline (group S)
Number of subjects: 30
Study: 9661647

Group type: EXPERIMENTAL
Intervention: iv arginine infusion (30 g) over 30 min
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: oral L-dopa (500 mg)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Baseline GH for the entire group
Number of subjects: 14

Group type: COMPARATOR
Intervention: Comparison of GH secretion between low and normal IGF-I levels
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: IGF-I and IGF binding protein-3 concentrations during GH stimulation
Number of subjects: 14
Study: 8136670

Group type: EXPERIMENTAL
Intervention: Withdrawal of diuretics
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control group (continued diuretic use)
Number of subjects: 63
Study: 2911450

Group type: EXPERIMENTAL
Intervention: Piroxicam
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: Diclofenac
Number of subjects: 267

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 267
Study: 31254130

Group type: COMPARATOR
Intervention: Placebo (low preformed vitamin A)
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Vitamin A at the recommended dietary allowance (400 μg retinol activity equivalents/day)
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Maize enhanced with β-carotene (2.86 mg/day)
Number of subjects: 143
Study: 29176414

Group type: EXPERIMENTAL
Intervention: Oval incision
Number of subjects: 29

Group type: COMPARATOR
Intervention: Diamond incision
Number of subjects: 29

Group type: COMPARATOR
Intervention: Inverted V incision
Number of subjects: 29
Study: 25438966

Group type: EXPERIMENTAL
Intervention: COMPAS
Number of subjects: 1563

Group type: EXPERIMENTAL
Intervention: ¡Cuídate!
Number of subjects: 1563

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 1563
Study: 23142485

Group type: EXPERIMENTAL
Intervention: Sounds of crying baby
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Sounds of violence
Number of subjects: 65
Study: 21978993

Group type: EXPERIMENTAL
Intervention: Palliative care (PC) provided immediately (fast-track group)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Palliative care (PC) provided after 12 weeks (control group)
Number of subjects: 52
Study: 22073456

Group type: EXPERIMENTAL
Intervention: Alumina ceramic abutment (CeraAdapt)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Zirconia ceramic abutment
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 23
Study: 17147808

Group type: EXPERIMENTAL
Intervention: Docetaxel, cisplatin, 5-FU (TCF)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Epirubicin, cisplatin, 5-FU (ECF)
Number of subjects: 71
Study: 12713212

Group type: EXPERIMENTAL
Intervention: After-school dance classes and a family-based intervention to reduce television viewing
Number of subjects: 61
Study: 10743869

Group type: EXPERIMENTAL
Intervention: Group no. 1 (substituted toothbrush monthly)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Group no. 2 (brushed only with the toothbrush provided at T0)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 20
Study: 8716377

Group type: EXPERIMENTAL
Intervention: Alphanumeric paging system
Number of subjects: 0
Study: 1558463

Group type: EXPERIMENTAL
Intervention: Phenelzine sulfate
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study: 3905054

Group type: EXPERIMENTAL
Intervention: 324 mg of aspirin daily for 12 weeks
Number of subjects: 1266

Group type: COMPARATOR
Intervention: aortocoronary bypass surgery
Number of subjects: 1266

Group type: COMPARATOR
Intervention: heparin therapy
Number of subjects: 1266

Group type: COMPARATOR
Intervention: nitrates, beta-blockers, calcium blockers, fibrinolytic therapy, and coronary angioplasty
Number of subjects: 1266
Study: 29804894

Group type: EXPERIMENTAL
Intervention: VRET plus YOH
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: VRET plus Propranolol
Number of subjects: 56

Group type: COMPARATOR
Intervention: VRET plus placebo
Number of subjects: 56
Study: 27151322

Group type: EXPERIMENTAL
Intervention: Flaxseed supplementation (30-g brown milled flaxseed daily)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Lifestyle modification plus flaxseed
Number of subjects: 44

Group type: COMPARATOR
Intervention: Lifestyle modification alone (Control)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Flaxseed supplementation
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 44
Study: 24075240

Group type: EXPERIMENTAL
Intervention: Hypromellose drops
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Tears Again™ liposome spray
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Combination of hypromellose drops and Tears Again™ liposome spray
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: All interventions
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Lubricants
Number of subjects: 48
Study: 22407618

Group type: EXPERIMENTAL
Intervention: SRP + PDT
Number of subjects: 12

Group type: COMPARATOR
Intervention: SRP
Number of subjects: 12
Study: 20683895

Group type: EXPERIMENTAL
Intervention: Breastfeeding
Number of subjects: 0

Group type: COMPARATOR
Intervention: Counseling for formula feeding
Number of subjects: 0
Study: 18190815

Group type: EXPERIMENTAL
Intervention: High-intensity multidisciplinary program of risk factor reduction
Number of subjects: 513

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 513

Group type: EXPERIMENTAL
Intervention: Retention rate
Number of subjects: 513

Group type: EXPERIMENTAL
Intervention: Patient and physician satisfaction
Number of subjects: 513
Study: 15920184

Group type: EXPERIMENTAL
Intervention: IV dexamethasone 0.25 mg/kg (D 0.25)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: IV dexamethasone 0.5 mg/kg (D 0.5)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: IV dexamethasone 1.0 mg/kg (D 1)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Saline (S)
Number of subjects: 168
Study: 14519792

Group type: EXPERIMENTAL
Intervention: Sterol ester group (n = 28) consuming croissants and magdalenas enriched with sterol esters (3.2 g/d) for 8 weeks
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group (n = 29) consuming standard croissants and muffins
Number of subjects: 57

Group type: COMPARATOR
Intervention: Comparison between SE group and control group
Number of subjects: 57
Study: 11051308

Group type: EXPERIMENTAL
Intervention: 25 mg promethazine
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 50 mg promethazine
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (sterile saline)
Number of subjects: 12
Study: 8792793

Group type: EXPERIMENTAL
Intervention: Quality assurance interventions
Number of subjects: 16
Study: 1418048

Group type: EXPERIMENTAL
Intervention: Terfenadine (oral therapeutic doses)
Number of subjects: 10
Study: 6747018

Group type: EXPERIMENTAL
Intervention: Methyldopa (500 to 2000 mg/day)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Propranolol (80 to 320 mg/day)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 31181395

Group type: EXPERIMENTAL
Intervention: Physical discipline classes identified among Black parents
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: Income
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: Child gender
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: Never-married status
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: Parental education
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: Neighborhood safety
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: Family stress
Number of subjects: 310
Study: 30303873

Group type: EXPERIMENTAL
Intervention: Single-port laparoscopy (SPL)
Number of subjects: 125
Study: 26614889

Group type: EXPERIMENTAL
Intervention: Thermal therapy with the Rezūm® System
Number of subjects: 197

Group type: COMPARATOR
Intervention: Control (rigid cystoscopy with simulated active treatment sounds)
Number of subjects: 197
Study: 25440375

Group type: EXPERIMENTAL
Intervention: Curcuminoids (C3 complex®); 1000 mg/day; n=50
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo; n=50
Number of subjects: 100
Study: 23020647

Group type: EXPERIMENTAL
Intervention: Telerehabilitation program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional rehabilitation program
Number of subjects: 0
Study: 18801825

Group type: EXPERIMENTAL
Intervention: Agomelatine 25 mg
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Agomelatine 50 mg
Number of subjects: 92

Group type: COMPARATOR
Intervention: Paroxetine 20 mg
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study: 17432676

Group type: EXPERIMENTAL
Intervention: Western medicine (group A)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Integrated Chinese and Western medicine (group B)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Endoscopic examination
Number of subjects: 116
Study: 16264036

Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP) at 5-10 cmH2O
Number of subjects: 16

Group type: COMPARATOR
Intervention: No CPAP
Number of subjects: 16
Study: 11916918

Group type: EXPERIMENTAL
Intervention: Blood letting (three phlebotomies of 500 ml at 2-week intervals)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Blood letting
Number of subjects: 100

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 100
Study: 10972349

Group type: EXPERIMENTAL
Intervention: Mineral supplementation and vitamin D dose of 1000 IU/day
Number of subjects: 32

Group type: COMPARATOR
Intervention: Lower dose of vitamin D (500 IU/day)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Preterm children
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control children
Number of subjects: 32
Study: 9365972

Group type: EXPERIMENTAL
Intervention: Atropine 0.02 mg.kg‐1
Number of subjects: 41

Group type: COMPARATOR
Intervention: Saline 0.9%
Number of subjects: 41
Study: 1540020

Group type: EXPERIMENTAL
Intervention: Purified peripheral blood polymorphonuclear leucocytes (PMNs) from patients with RA
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Patients with RA not receiving drugs or receiving only NSAIDs
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Patients with RA receiving second line treatment in addition to NSAIDs
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Patients with RA
Number of subjects: 31
Study: 3548209

Group type: EXPERIMENTAL
Intervention: Intravenous oxytocin (Group A)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: 3 mg PGE2 as a vaginal suppository (Group B)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (Group A)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (Group B)
Number of subjects: 38
Study: 31271691

Group type: EXPERIMENTAL
Intervention: Enrollment using EFIC procedures after attempting to reach a parent
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Enrollment using EFIC procedures with no attempt to obtain informed consent
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Enrollment only with written informed consent
Number of subjects: 102
Study: 29132805

Group type: EXPERIMENTAL
Intervention: TEE probe
Number of subjects: 100

Group type: COMPARATOR
Intervention: Vascular probe
Number of subjects: 100